Effects of Lifestyle Intervention in the Biological Aging in Prediabetes

June 8, 2024 updated by: Ahmed Shafi Alenezi, King Saud University

Effects of a 6-month Lifestyle Intervention Program in the DNAm PhenoAge, SOST, and GDF15 Markers of Biological Aging in Adults With Prediabetes

Lifestyle modifications, including dietary changes and increased physical activity, play a crucial role in controlling complications to reduce or eliminate them. As well as controlling disturbances in biochemical markers such as DNAm PhenoAge, and signs of aging such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15). This study seeks to address this dilemma by focusing on specific groups of elderly Saudis with prediabetes . Lifestyle changes in elderly Saudis with prediabetes show promise in reducing or eliminating complications. The potential insights derived from this research extend beyond academia, offering tangible benefits for clinical practice and public health

The proposed study will be implemented to achieve the following objective:

  1. To determine changes in DNAm PhenoAge of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program.
  2. To determine changes in other candidate senescence markers such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15) of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program.

Study Overview

Detailed Description

Participants will be received at all healthcare centers in Arar, Kingdom of Saudi Arabia. They will be informed about the lifestyle modification intervention programme. The interview will take place in a designated and prepared place.

If approved, informed consent is signed. The procedures begin with filling out questionnaires and basic assessments include anthropometric, blood pressure and blood pressure measurements. The anthropometric measurements will be performed by well-trained medical staff. Height (m) and weight (kg) will be measured in light clothing without shoes. Waist, hip, circumference (cm) will be measured using a standard tape measure. BMI will be calculated by dividing weight in kilograms by the square of height in metres. Your blood pressure will be measured at each visit after adequate rest.

Dietary intake will be assessed through a validated food frequency questionnaire. Assessments will be repeated twice (at baseline and 6 months) in both groups. Fasting blood samples will then be collected using a sterile blood collection device to perform blood tests for biological age using self-analyzers in the internal laboratory of the participating primary health care centers. Tests will include complete blood count, serum albumin, creatinine, fasting glucose, C-reactive protein, alkaline phosphatase and other markers of aging such as SOST and DGF-15. Through these tests, the DNAm PhenoAge will be calculated through an online platform (https://thrivous.com/pages/biological-age Calculator).

In light of the results, participants will be included or excluded, and participants included in the program will continue with us through follow-up with nutritional awareness. 500 participants will be involved and all participants will be advised to:

Weight loss (5% of basic weight), exercise (4 hours/week), moderate fat consumption, and a diet rich in fiber.

5- Participants will receive individual, detailed and ongoing nutritional counseling through the study dietitian every two weeks, and they will also be encouraged to participate in physical activities. Table The detailed intervention for both groups is shown below. The measurements and analyzes will be repeated a few months after the beginning, and based on this, the Lifestyle Modification Group (LMP) will be determined: those who agreed and followed the previous instructions and advice.

The control group (CG): They are those who did not receive health education or did not follow previous instructions or advice.

Study Type

Interventional

Enrollment (Estimated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Clinical diagnosis of pre-diabetes for all Saudis aged 30 years and above, males and females
  2. They must be able to exercise and be able to follow a diet

Exclusion Criteria

  1. Insulin-dependent diabetes and non-diabetic patients
  2. People with diseases that prevent them from participating and doing exercises

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lifestyle Modification Group (LMP)

They are the people who will follow the lifestyle modification program, which is:

Dietary counseling and monitoring: reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet Physical activity: moderate exercise (150 minutes/week)

Dietary counseling and monitoring:

Reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet.

Participants will receive individual, detailed, ongoing nutritional counseling by the study dietitian every two weeks.

Physical activity:

Participants will also be encouraged to participate in physical activities. moderate exercise (150 minutes/week)

Placebo Comparator: Control group (CG)
They are people who will not follow the lifestyle modification program or they did not know about this program

Dietary counseling and monitoring:

Reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet.

Participants will receive individual, detailed, ongoing nutritional counseling by the study dietitian every two weeks.

Physical activity:

Participants will also be encouraged to participate in physical activities. moderate exercise (150 minutes/week)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the rate of measurements of Age marker Albumin post intervention
Time Frame: 6 months
Change in Albumin (g/L)
6 months
Change in the rate of measurements of Age marker fasting glucose post intervention
Time Frame: 6 months
Change in fasting glucose (mmol/L)
6 months
Change in the rate of measurements of Age marker Creatinine post intervention
Time Frame: 6 months
Change in Creatinine (umol/L)
6 months
Change in the rate of measurements of Age marker C-Reactive Protein post intervention
Time Frame: 6 months
Change in C-Reactive Protein (mg/dL)
6 months
Change in the rate of measurements of Age marker Alkaline Phosphatase post intervention
Time Frame: 6 months
Change in Alkaline Phosphatase (U/L)
6 months
Change in the rate of measurements of Age marker White Blood Cell Count (WBC) post intervention
Time Frame: 6 months
Change in White Blood Cell Count (WBC) (10^3/uL)
6 months
Change in the rate of measurements of Age marker Lymphocyte post intervention
Time Frame: 6 months
Change in Lymphocyte (%)
6 months
Change in the rate of measurements of Age marker Mean Cell Volume (MCV) post intervention
Time Frame: 6 months
Change in Mean Cell Volume (MCV) (fL)
6 months
Change in the rate of measurements of Age marker Red Cell Distribution Width (RDW) post intervention
Time Frame: 6 months
Change in Red Cell Distribution Width (RDW) (%)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the rate of measurements of Age marker SOST post intervention
Time Frame: 6 months
Change in SOST(pmol/L)
6 months
Change in the rate of measurements of Age marker GDF15 post intervention
Time Frame: 6 months
Change in GDF15 (10^3 pg/mL)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Shaun B Sabico, M.D.PhD, King Saud University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2024

Primary Completion (Estimated)

August 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

May 20, 2024

First Submitted That Met QC Criteria

May 31, 2024

First Posted (Actual)

June 4, 2024

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 8, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PreDiabetes

Clinical Trials on Providing nutritional counselling

Subscribe